CHEK2 and melanoma: The final 83 pathogenic/likely pathogenic (P/LP) germline variants (66 unique) in 71/264 (26.8%) melanoma patients were detected in 42/217 targeted genes (Supplementary Table S3) and included five copy number variants (CNV; two in CHEK2 and SLC45A2, respectively, and one in TRPM1; Supplementary Figure S1).